About: Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.04 (-13.73%)
ACW ASX Actinogen Medical Ltd
Actinogen Medical Ltd share price
ACW price activity
Last Price
$0.040
Change (24hr)
-0.01 AUD (-13.73%)
Volume
7.10M
Volume (4w avg)
-
Open
$0.05
Day Range
$0.04 - $0.05
Previous Close
$0.05
Last Trade
13 Oct, 5:10 am GMT+0
Delayed
13 Oct, 5:10 am GMT+0
ACW price performance
Delayed
13 Oct, 5:10 am GMT+0
ACW Market Signals